Histone Deacetylases Activate Hepatocyte Growth Factor Signaling by Repressing MicroRNA-449 in Hepatocellular Carcinoma Cells

被引:190
作者
Buurman, Reena [1 ]
Guerlevik, Engin [2 ]
Schaeffer, Vera [1 ]
Eilers, Marlies [1 ]
Sandbothe, Maria [1 ]
Kreipe, Hans [3 ]
Wilkens, Ludwig [1 ,3 ]
Schlegelberger, Brigitte [1 ]
Kuehnel, Florian [2 ]
Skawran, Britta [1 ]
机构
[1] Hannover Med Sch, Inst Cell & Mol Pathol, D-30625 Hannover, Germany
[2] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany
[3] Hannover Med Sch, Inst Pathol, D-30625 Hannover, Germany
关键词
HGF; Liver Cancer; Mouse Model; RNA Processing; HUMAN CANCER-CELLS; EPIGENETIC THERAPY; C-MET; GENE-EXPRESSION; PROSTATE-CANCER; UP-REGULATION; INHIBITORS; TARGETS; MIR-449A; PATHWAY;
D O I
10.1053/j.gastro.2012.05.033
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Histone deacetylation regulates chromatin remodeling and transcriptional down-regulation of specific genomic regions; it is altered in many types of cancer cells. We searched for microRNAs (miRs) that are affected by histone deacetylation and investigated the effects in hepatocellular carcinoma (HCC) cells. METHODS: HCC cell lines (HepG2, HLE, HLF, and Huh7) and immortalized liver cell lines (THLE-2 and THLE-3) were incubated with the histone deacetylase inhibitor trichostatin A. Differentially expressed messenger RNAs (mRNAs) and miRs were identified by expression profiling. Small interfering RNAs were used to reduce levels of histone deacetylases (HDAC) 1-3, and HCC cell lines were transfected with miR-449. We evaluated growth of xenograft tumors from modified cells in nude mice. Cells were analyzed by immunoblot and luciferase reporter assays. We analyzed HCC samples from 23 patients. RESULTS: HDAC1-3 were up-regulated in HCC samples from patients. In cell lines, inhibition of HDAC significantly increased levels of hsa-miR-449a. c-MET mRNA, which encodes the receptor tyrosine kinase for hepatocyte growth factor, is a target of miR-449. Incubation of HCC cells with trichostatin A or transfection with miR-449 reduced expression of c-MET and phosphorylation of extracellular signal-regulated kinases 1 and 2 (downstream effectors of c-MET), increased apoptosis, and reduced proliferation. Huh-7 cells transfected with miR-449 formed tumors more slowly in mice than cells expressing control miRs. HCC samples from patients had lower levels of miR-449 and higher levels of c-MET than human reference. CONCLUSIONS: In HCC cells, up-regulation of HDAC1-3 reduces expression of miR-449. miR-449 binds c-MET mRNA to reduce its levels, promoting apoptosis and reducing proliferation of liver cells. Expression of miR-449 slows growth of HCC xenograft tumors in mice; this miR might function as a tumor suppressor.
引用
收藏
页码:811 / +
页数:25
相关论文
共 52 条
  • [1] MicroRNAs: Target Recognition and Regulatory Functions
    Bartel, David P.
    [J]. CELL, 2009, 136 (02) : 215 - 233
  • [2] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29
  • [3] Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies
    Bhalla, KN
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (17) : 3971 - 3993
  • [4] Met, metastasis, motility and more
    Birchmeier, C
    Birchmeier, W
    Gherardi, E
    Vande Woude, GF
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (12) : 915 - 925
  • [5] IDENTIFICATION OF THE HEPATOCYTE GROWTH-FACTOR RECEPTOR AS THE C-MET PROTOONCOGENE PRODUCT
    BOTTARO, DP
    RUBIN, JS
    FALETTO, DL
    CHAN, AML
    KMIECIK, TE
    VANDEWOUDE, GF
    AARONSON, SA
    [J]. SCIENCE, 1991, 251 (4995) : 802 - 804
  • [6] Treatment of hepatocellular carcinoma
    Colombo, M
    [J]. JOURNAL OF VIRAL HEPATITIS, 1997, 4 : 125 - 130
  • [7] Prospects: Histone deacetylase inhibitors
    Dokmanovic, M
    Marks, PA
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2005, 96 (02) : 293 - 304
  • [8] Fahrner JA, 2002, CANCER RES, V62, P7213
  • [9] MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma
    Fang, YuXiang
    Xue, Jing-Lun
    Shen, Qi
    Chen, Jinzhong
    Tian, Ling
    [J]. HEPATOLOGY, 2012, 55 (06) : 1852 - 1862
  • [10] Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer
    Fraga, MF
    Ballestar, E
    Villar-Garea, A
    Boix-Chornet, M
    Espada, J
    Schotta, G
    Bonaldi, T
    Haydon, C
    Ropero, S
    Petrie, K
    Iyer, NG
    Pérez-Rosado, A
    Calvo, E
    Lopez, JA
    Cano, A
    Calasanz, MJ
    Colomer, D
    Piris, MA
    Ahn, N
    Imhof, A
    Caldas, C
    Jenuwein, T
    Esteller, M
    [J]. NATURE GENETICS, 2005, 37 (04) : 391 - 400